Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Novo Nordisk A/S said a bigger dose of the main ingredient in Wegovy, its top-selling weight-loss drug, helped patients shed ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Wegovy comes as a liquid solution inside a prefilled single-dose pen for subcutaneous injection (an injection under your skin). For more details on Wegovy, including limitations of use ...

Both are made by Novo Nordisk. "Ozempic is the only version among the weekly injectables — Ozempic, Wegovy, Zepbound and ...

(C cells are a kind of cell in the thyroid gland.) This side effect depended on Wegovy’s dosage and length of treatment. It’s not known if the same effect would happen in humans. Because of ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...